Aclaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research.

Medical - Diagnostics & Research
US, Wayne [HQ]

Resulting Ratios

11 Records · Starting from 2013
Loading...
End of ACRS's Analysis
CIK: 1557746 CUSIP: 00461U105 ISIN: US00461U1051 LEI: - UEI: -
Secondary Listings
ACRS has no secondary listings inside our databases.